A B S T R A C T Interactions between glucose and argiRline and a mixture of 20 amino acids found in normal rat serum were studied in the isolated perfused rat pancreas of normal rats, with release of immunoreactive glucagon and insulin as parameters. Secretion of both pancreatic hormones was low during the steady state, whether glucose (5 mMA) was included in the perfusion medium or not. This glucose concentration significantly stimulated insulin release twofold and resulted in an 80% inhibition of basal glucagon release. Arginine and the amino acid mixture were potent stimulants of both hormones. Secretion of both hormones followed identical biphasic response patterns after addition of arginine or the amino acid mixture. However, stimulation of insulin release occurred only when glucose was included, whereas both phases of glucagon release were elicited in the absence of glucose and markedly reduced in its presence. The dose-dependency curves of hormone release due to arginine on one hand and the amino acid mixture on the other differed substantially: with arginine, release of insulin and glucagon was linear between a concentration of 0.3 and 20 mM. In contrast, the amino acid mixture resulted in half-maximal release for both hormones between a concentration of 3 and 4.5 mAM, and maximal release between 6 and 8 mAM. The dose-dependencies of glucose modulation of a-and P-cell activity were also different: when the amino acid mixture was maintained at 15 mMI and glucose varied (0-6.25 mM), no insulin release occurred until glucose was above 2.5 mM, whereas incremental inhibition of glucagon occurred through the complete dose range. It was also observed that glucose inhibition of amino acid-stimulated glucagon reThis wdvork was presented in part at the meeting of the lease was dissociated from glucose-dependent increase of insulin release. These studies indicate that: (a) the a-cell, like the P-cell, secretes at a low basal rate; (b) hypoglycemia per se is a weak stimulus for glucagon secretion compared to the high efficacy of a physiologic amino acid mixture; (c) glucose plays opposite roles in the mechanisms leading to amino acid-induced hormone release from the a-and P-cells, functioning as an inhibitor in the first case and a permissive agent in the second, and (d) the data are compatible with the postulated existence of glucose and amino acid receptors in both the a-and P-cells.
INTRODUCTION
Glucagon and insulin are considered to be important hormones for the maintenance of minute-to-minute fuel homeostasis of the organism (1) . The a-and P-cells, the source of these hormones, are chemoreceptor cells with a broad spectrum capable of rapid response to almost any alteration in the body's supply of assorted nutrients. Since the actions of insulin and glucagon on peripheral tissues in regard to carbohydrate, protein, and fat metabolism are clearly antagonistic, it is not surprising that the mechanisms responsible for the secretion of these two hormones are likewise regulated in opposite ways; in general terms, conditions which stimulate a-cells usually inhibit P-cells and vice versa. Both glucose and fatty acids, for example, cause insulin release, whereas glucagon release appears to be inhibited by these substances (2) (3) (4) . Amino acids, however, seem to present an exception to this general rule, since they lead to hormone release from both a-and P-cells (1, (5) (6) (7) . In spite of this overall understanding of a-and p-cell physiology, there is little detailed knowledge about possible complex interactions of the major small calorigenic molecules (i.e. amino FIGURE 1 Basal insulin and glucagon release from the pancreas perfused with and without glucose. The pancreas was perfused for 75 min without changing the composition of the perfusate but the reservoir was switched at 0 and 30 min as in perfusions with the amino acid stimulants. After 10 min preperfusion, three samples were taken (t-5, t-2, and to). The data recorded in the preperfusion period represents the mean SEM of all experiments performed in this study and also of those obtained in a parallel study' (insulin release without glucose, i = 84; insulin release + 5 mM glucose, n = 76; glucagon release without glucose, n =95 and glucagon release + 5 mM glucose, n = 76). The values given during the time periods to.-t3o and tso.s-too are the means ±SEM of the rates of release of both hormones and correspond to the stimulatory and poststimulatory time periods in perfusions performed with amino acids (insulin release without glucose, n = 8; insulin release + 5 mM glucose, n = 6; glucagon release without glucose, n = 3; and glucagon release with 5 mM glucose, n = 3). See also Table I. , Insulin and glucagon release without glucose; ---, insulin and glucagon release with 5 mM glucose; IRI, immunoreactive insulin; IRG, immunoreactive glucagon.
ketone bodies, and sugars) at the cellular or biochemical level. It seems particularly important to comprehend the multiple functions that the glucose molecule might serve in regulating the chemosensitivity of the a-and P-cells, since it has become increasingly clear that glucose modulates the responsiveness of these cells to other stimuli, in addition to its well-known direct insulin-releasing action from ,-cells. The multiple actions of glucose on islet cells have been explained in various ways. The frequently quoted unifying concept proposed by Edwards and Taylor (2) attributes glucose stimulation of P-cells on one hand and glucose inhibition of a-cells on the other to increased provision of fuel or of critical metabolites and cofactors, i.e. insulin release occurs when the P-cells are supplied with energy and an optimal metabolite and cofactor constellation, whereas glucagon release ensues when the energy level (i.e. ATP and P-creatinine) is lower in a-cells. This general notion has been extended by Unger and Lefebvre and collaborators (1, 5, 8) , who believe that in the a-cells the provision of metabolic energy from glucose, and consequently the inhibitory action of glucose, are insulin-dependent.
Another widely accepted view holds that the two types of islet cells are fundamentally different physiologically: a-cells are considered as inherently active cells, i.e. as pacemaker cells normally curbed by glucose levels in the physiological range, whereas P-cells require external stimuli to become activated (1) . To submit these various concepts to further experimental testing, the present physiological and pharmacological studies were initiated with the isolated perfused rat pancreas. This paper is the first report of this series of studies. The major objective was to assess the possible role of glucose in regulating the function of a-and 8-cells when stimulated by arginine or a mixture of 20 natural amino acids and to elucidate the kinetics of glucagon and insulin release in the isolated perfused rat pancreas to these stimuli as an initial step before correlation of hormonal release with possible biochemical changes occurring within the aand P-cell. 820 Pagliara, Stillings, Hover, Martin, and Matschinsky Fig. 1 . The values given during the time period t-5-to are the mean ±SEM of the rates of release at time points t-5, t2, and to for both hormones. The values given during the time periods to.5-t3o and t30.5-t60 are the mean ±SEM of the average rates of release of both hormones when perfusions were performed with and without 5 mNM glucose (see legend to Fig. 1 ). The pancreas was isolated and perfused by the procedure described by Grodsky et al. (9) with minor modifications (10) . After an overnight fast, the animals were atropinized (0.1 mg/kg i.p.) and anesthetized with pentobarbital (45 mg/kg i.p.). Atropine was given since it prevented respiratory problems that occasionally arose during the surgical procedure. The pancreas was isolated en bloc with the spleen, stomach, and proximal portion of the duodenum. Polyethylene cannulae were inserted into the celiac artery and portal vein, and the organ complex was placed in an incubator and perfused at a constant 350C without recycling the medium. The flow rate was frequently measured and was maintained constant between 5 and 6 ml/min. The perfusate contained routinely the following components: NaCl, 120 mM; KCI, 4.7 mM; MgSO4, 0.8 mM; CaCI2, 2.5 mM; KH2PO4, 1.2 mM; NaHCO3, 25 mM; and dextran 7-8%. Other additions were made as described in the text below or in the legends of the appropriate figures and tables. Before perfusion, the medium was warmed to 350C and gassed with a mixture of O2 and CO2 (95: 5).
The resulting pH was 7.4. Perfusion wit/h amino acids in the prcseucee anod absen1ce of basal glucose. For each experimental condition, at least six separate perfusions were performed, half of which had 5 mM glucose present throughout. This concentration of glucose was selected since it has minor effects on basal insulin release (11, 12) . In all experiments in which glucose and/or amino acids were studied, the pancreas was perfused for 15 min before exposure to the amino acid stimiulant. The period of stimulation lasted 30 min and was followed by another control period of 30 min by perfusion in the absence of the amino acid(s ). Cystine and tyrosine were separately added to the perfusion medium in solid forms because of solubility problems. The relative concentrations of these two amino acids were always 1.9 and 2.2%, respectively. In the above experiments, 0.5-ml samples were obtained at suitable intervals from the cannula in the portal vein, briefly cooled on ice, and frozen for storage at -20'C until assayed. 25 samples were taken in each experiment; of these 3 were during the preperfusion period of 15 min (at t-.., t-2, and to) to obtain the basal insulin and glucagon release levels; after the switch to the medium containing the stimulant under study, samples were collected 0.5 min after the change, then every minute for 5 min, and finally every 5 min for the remaining 25 min of stimulation. The same schedule of sampling was applied when the circulation was switched back to the control solution to study the poststimulatory activity. The rates of insulin and glucagon release were calculated by multiplying the concentration of the respective sample by the flow rate, which was measured at frequent intervals. Mo., fraction V) and 1,000 kallikrein inactivator units Trasylol/ml (FBA Pharmaceuticals, New York). The final antibody dilution during this step was 1:32,000. In the standard curves Krebs-Henseleit-Dextran was added in the same concentrations as in the sample tube. The tubes were incubated for 4 days at 4VC; the preincubation extended over 24 h and the incubation with 'I lasted for 72 h. Separation of bound from free glucagon was accomplished by precipitation of the bound with goat antiguinea pig gamma globulin and normal guinea pig serum.
The lower limit of detection of the assay system is 5.0 pg. The standard deviation of the intrassay variability is 8% and that of the interassay variability 12%. All substances added to the perfusion medium were tested at the highest concentration used for possible interference in the immunoassays.
RESULTS
Basal glucagon and insulin release. Secretion of both pancreatic hormones was low during the steady state, whether basal glucose (5 mM) was included in the perfusion medium or not ( Fig. 1 , Table I ). This basal release varied substantially both among individual experiments and during the course of a single perfusion. However, the fluctuations of the base line would appear to be a minor problem, considering the high rates of release seen during amino acid stimulation.
Perfusion with 5 mM glucose doubled insulin release during each period corresponding to the prestimulatory (t-a-to), stimulatory (to.-tao), and poststimulatory Within both types of perfusion (with or without glucose), the average insulin release rates corresponding to the prestimulatory and stimulatory phases were virtually identical. However, in the poststimulatory phase, the average insulin release rate for both conditions was significantly lower than the corresponding prestimulatory and stimulatory periods (Fig. 1 , Table I ).
Perfusion with 5 mM glucose inhibited basal glucagon secretion. The average rates of glucagon release (in nanograms per minute, mean ±SEM) when compared to perfusions with 5 mM glucose were: t-5 to to, 1.42±0.10 (n = 285); vs. 0.37±0.01 (n = 228); to., to tOo, 1.5±0.07 (n=33) vs. 0.31±0.03 (n=33) and tato. to too, 0.84±0.04 (n = 33) vs. 0.29±0.02 (n = 33), for all values P < 0.001. As with insulin, within both types of perfusion (with or without glucose), the average glucagon release rates corresponding to the prestimulatory and stimulatory phases did not differ. However, there was a significant decrease in the average glucagon release during the poststimulatory phase in the perfusions without glucose (P < 0.001, Table I ). Low rates of basal insulin and glucagon release were also observed in an independent study with the isolated perfused canine pancreas (6) .
We felt that this data justified the subtraction of the prestimulatory (t-5 to to) insulin and glucagon release rates, obtained from each individual perfusion when calculating rates of release above basal levels in the presence of an amino acid stimulus.
The effect of arginine and other individual amino acids on a-and 1-cells. Arginine, in concentrations from 0.3 to 20 mM, had little to no effect by itself in increasing insulin secretion. It is particularly striking that in the absence of glucose the initial hormone peak is clearly absent ( Fig. 2A) . However, when 5 mM glucose was included in the perfusate, graded stimulation of insulin release occurred readily with increasing concentrations of the amino acid and the biphasic pattern previously described for glucose and many other stimulants was present (6, 11, 12) . The peak of the first phase was obtained between 30 and 60 s after the switch with all concentrations and the nadir occurred between 3 and 5 min. A sustained second phase was observed with 10 and 20 mM arginine. After 30 min of continued perfusion with both arginine and 5 mM glucose, the switch to 5 mM glucose alone resulted in a rapid de- In selected studies with 3 mM asparagine or alanine, both in the presence and absence of 5 mM glucose the aand P-cell responses were quantitatively and qualitatively comparable to the results seen with corresponding concentrations of arginine (data not shown).
The present results with arginine agree generally with data from other in vitro studies and particularly with the findings of Iversen, who used the isolated perfused dog pancreas (6) , and with the findings of Levin, Grodsky, Hagura, Smith, and Forsham (16) , who also employed the isolated perfused rat pancreas. However, in the latter study, arginine had a more pronounced effect on insulin release even in the absence of glucose, particularly at the very high levels used (16) .
Studies with a mixture of 20 amino acids. Since unphysiologically high concentrations of arginine and of other individual amino acids were used in the experiments just described (10-200 times the physiological levels) the studies were repeated with a mixture of 20 natural amino acids in concentrations and proportions found in normal rat serum (13) . Serum concentrations of total amino acids after an overnight fast are approximately 3 mM (13) and are likely to increase to 4.5-6 mM postprandially.
The insulin release profiles with the amino acid mixture were qualitatively similar to those observed with arginine (Fig. 2C) perresponsiveness to glucose became apparent. In this regard, arginine and the amino acid mixture differ markedly from high glucose, leucine, isoleucine, ketone bodies, cetrain fatty acids, and a-keto-monocarboxylic acids, all of which lead to poststimulatory hyperresponsiveness to basal glucose (17) . The data indicate that the sensitization of the A-cells to basal glucose is not simply a consequence of sustained excitation and secretion. It is conceivable that hyperresponsiveness to glucose is induced only by those substances that enhance glucose metabolism concomitant with triggering release. Consistent with this explanation are recent findings in our laboratory that show that in isolated islets, 10 mM L-isoleucine markedly stimulates lactate production from basal glucose, whereas the same level of arginine and of the mixture of 20 amino acids has little effect on lactate formation.2
As with arginine alone, glucagon release was markedly and progressively enhanced by increasing concentrations of the amino acid mixture; the biphasic pattern occurred with concentrations as low as 1 mM (Fig. 2D) . All secretion profiles were drastically suppressed by the presence of 5 mM glucose.
The effect of acute hypoglycemia on a-and 8-cells previously exposed to physiological levels of amino acids (4.5 mM) and glucose (6.25 mM) was tested (Fig. 3) . There was a definite delay after the switch to the glucose-free solution before the glucagon response became apparent. The release profile was monophasic, lacking the pronounced initial spike seen on exposure to amino acids. In contrast to the glucagon response, the first 2 Unpublished data. peak was present in the insulin profile when basal glucose was reintroduced.
In the control experiments (amino acids omitted) abrupt aglycemia produced a comparatively minor glucagon response (Fig. 3) . This experiment suggests that the tonic influence of plasma amino acids and the acute fall in blood glucose may be the primary factors responsible for the release of glucagon during hypoglycemia in vitro. The above factors together with inputs from the autonomic nervous system may in combination be responsible for glucagon release during hypoglycemia in vivo (18) .
Characteristics of dose-response curves due to arginine and the amino acid mixture. The concentration dependency of glucagon and insulin release provoked by arginine and amino acids, both in the absence and presence of basal glucose, exhibits features of probable physiological significance, as illustrated in Fig. 4 . The total hormone release during exposure to the stimulant is recorded, neglecting the multiphasic kinetics of release. The system, which responds to arginine plus glucose by releasing insulin, was not saturated by arginine, even at 20 mM. Unlike arginine, the amino acid mixture together with 5 mM glucose resulted in half-maximal secretion at 4.5-5 mM and maximal secretion with 6-8 mM levels of amino acid, concentrations within the physiologic range. The steepness of the curve obtained with the mixture suggests the possibility of cooperative effects among the different amino acids. That this might be the case is also suggested by the results of corresponding in vivo studies (7, 19) . The relative contribution of the individual amino acids to the overall response remains to be unraveled. Basal glucose inhibited glucagon release due to arginine and to the amino acid mixture by approximately 80% at all levels of the stimulants. As with insulin, the dose-response curves demonstrate the failure of arginine to saturate the system involved in glucagon secretion, whereas the amino acid mixture with or without glucose resulted in near-maximal stimulation within the physiologic range of amino acid concentration.
Glucagon and Insulin Secretion in the Perfused
Concentration dependency of glucose actions allowing a-cell stimulation and leading to ,-cell inhibition. In all studies described above, a constant level of 5 mM glucose was employed. The permissive and inhibitory action of glucose on P-cells and a-cells, respectively, was further investigated by maintaining the amino acid mixture at a level of 15 mM and perfusing with increasing concentrations of glucose (0-6.25 mM) (Fig.  5 , Tables II and III) .
The permissive action of glucose in allowing insulin release by amino acids revealed a clear threshold of the effect at 2.5 mM glucose; no insulin release occurred below this concentration (Fig. 5 , Table II ). In contrast, the inhibition of a-cell activity became manifest at the lowest glucose levels used (1.25 mM) and further increased up to 6.25 mM, at which point glucagon secretion was 6-7% of the secretion rate of the perfusions without glucose (Fig. 5 , Tables II and III) .
Both the permissive and the inhibitory actions of glucose on P-and a-cells, respectively, manifest themselves ' The terms "permissive and inhibitory actions of glucose" seem reasonable in a physiologic sense but are not meant to imply any knowledge about the molecular mechanisms underlying the phenomena described by them. Table II ). The a-cells are even more sensitive to the action of glucose; maximal inhibition of the first phase of the glucagon response is already reached at the lowest glucose levels tested (1.25 mM). Glucose suppression of the second phase of glucagon secretion was, however, less effective, and inhibition was incremental over the entire range of glucose concentrations (Fig. 5 , Tables II and III) . The most dramatic change occurred when the glucose level was increased from 2.5 to 3.75 mM. These data might indicate that in the absence of stimulated insulin release, glucagon and insulin release during the first phase are unrelated, but do not preclude an interdependence in the secretion of the two hormones during the second phase, when the rates of insulin release are high (Fig. 6 ). These results imply that the glucose effect on a-cells may at least in part be independent of the insulin-releasing capacity. It is, however, not possible with the present information to determine whether the low base-line levels of insulin might not suffice to facilitate glucose entry into the a-cell, leading to inhibition.
It is noteworthy that in the prestimulatory phase, without amino acids in the perfusate, significant suppression of glucagon secretion occurs only at 5-6.25 mM concentrations (P < 0.01 for both) (Table III ). In the poststimulatory phase, except for the first minute after removal of the amino acid stimulus, secretion rates were lower than in the prestimulatory phase and no further inhibition of glucagon release was apparent with increasing glucose concentrations (Table III) .
DISCUSSION
Two aspects of the present results deserve detailed comment; (a) the physiological role of glucose as primary modulator of a-and P-cell function, and (b) the molecular mechanisms possibly underlying the multiple actions of glucose on islet cells.
Physiologic modulation of a-and P-cell function by glucose. The picture of physiological a-and 8-cell function evolving from the present study and from the data in the literature may be sketched as follows: in the absence of external stimuli, which would include circulating substrates and possibly stimulatory inputs from the autonomic nervous system (18) and other unknown humoral factors, both a-cells as well as P-cells are in a state of rest, exhibiting low basal rates of hormone release only a few percent of their secretion potential. The data are incompatible with the view that Table II ).
a-cells have substantial spontaneous activity when deprived of glucose (1) . If the latter hypothesis were correct, one could expect aglycemic perfusion of the pancreas to result in a marked elevation of glucagon release. The consistent decrease in basal glucagon release with 5 and 6.25 mMI glucose (Fig. 1 the nerve terminal in the absence of a nerve impulse, as manifested by miniature end plate potentials (20) . In the absence of glucose, a-cells are sensitized, able to respond readily to physiological levels of amino acids, whereas the A-cells are unresponsive to this major group of fuel molecules. This nonresponsiveness of the P-cells devoid of glucose extends to almost all physiologic stimuli, studied so far, including fatty acids, ketone bodies, secretin, pancreozymin, glucagon, and certain metabolites of amino acids. Glucose profoundly alters the chemosensitivity of both kinds of cell, but oppositely. Secretion of glucagon, induced by amino acids or by enteric hormones (6) , is partially inhibited by physiologically low glucose levels (1-2 mM), and is almost entirely blocked by normal sugar levels (5-6 mM).
Glucose sensitizes the P-cells to secretory stimuli, in contrast to its action on a-cells. It was shown here with amino acids and in a parallel study with DL-B-hydroxybutyrate' that there is a threshold close to 2.5 mM for the permissive action of glucose that allows other molecules to release insulin, and that the glucose effect increases dramatically at levels exceeding this threshold. This should be physiologically advantageous. It would make little sense if the P-cells responded with insulin output to other molecules if the blood sugar were dangerously low, i.e., 2.5 mM or less. Glucose can therefore be considered as a safety switch, turning off the P-cells during hypoglycemia and sensitizing them when the blood sugar is normal or higher. As the blood sugar ' Manuscript in preparation.
falls, a-cells become deinhibited and the stimulatory factors gain increasing influence, thus curbing hypoglycemia. Similar ideas concerning the modulating role of glucose in 8-cell responsiveness were derived from in vivo studies in man, using arginine, tolbutamide, and glucagon as secretagogues (21, 22) .
What is the physiological significance of the biphasic glucagon response to amino acid stimulation? Since the temporal profile of amino acid-induced glucagon release resembles that of insulin release due to high glucose or amino acids plus basal glucose, one cannot help asking whether the biphasic glucagon release pattern might have similar significance as attributed to the biphasic insulin secretion pattern, and whether the widely accepted two-compartment model of insulin release applies to glucagon secretion from the a-cells as well. It is difficult to describe physiologic conditions that might cause substrate-induced biphasic glucagon release due to rapid rises in amino acids in blood, in contrast to the frequently encountered dramatic changes of the blood sugar levels. The vampire bat is probably one of the few mammals exhibiting large and rapid fluctuations in serum amino acids, which occur after a blood meal.' However, the possibility that neuronal and enterohormonal factors might modulate a-cell function in ways that demand the capacity for an abrupt, biphasic response must be considered in most other species.
With the information currently available, it is impossible to explain the mechanism of the biphasic response 'George Cahill, Jr. Personal communication. 828 Pagliara, Stillings, Hover, Martin, and Matschinsky (23) propose that glucose suppression of glucagon secretion is a consequence of elevated insulin levels at the a-cells, and they also imply that amino acid-induced insulin release depends convjersely upon elevated glucagon concentrations at the P-cells. At first glance, the data in this paper and in the literature (1, 2, 5-7, 23) seem to be compatible with this view. However, a closer look at the results of the present study reveals that the rates of glucagon and insulin release are not always inversely related, as one would expect if this concept were correct. In particular, low glucose levels inhibit the first phase of amino acidinduced glucagon release without augmenting basal insulin release. IMore convincingly, it was found in a parallel study wvith pancreases of both alloxan-and streptozotocin-diabetic rats that glucose suppression of a-cell function is independent of insulin (24) .
From the present data, it seems unlikely that amino acid-induced insulin release is in any way dependent upon concomitant glucagon secretion, since insulin secretion is maximal when glucagon release is low or almost ceases. Furthermore, there are physiological stimulants with no effect on glucagon release but with powerful insulin-releasing action (e.g. P-hydroxybutyrate').
Assuming then, in contrast to most current beliefs, that glucose acts directly on a-as well as on P-cells, one has to consider a priori the following possible mechanisms for its action. (The mechanism could be the same in each type of cell except for an opposite sign.) They are: (a) transport of glucose into the cell; (b) phosphorylation of glucose; (c) further metabolism of glucose by the cell; (d) interaction of glucose with a receptor on the external surface of the cell; and (e) various combinations of the above.
Extensive studies have been performed to differentiate which of the above molecular mechanisms might be the basis of the permissive action of glucose on the P-cells (11, 17, (25) (26) (27) (28) (29) , whereas analogous studies of the glucose modulation of a-cell function are scanty (2, 30 FIGURE 6 Relationship between insulin and glucagon in the first phase and the second phase of release above basal secretion rates caused by 15 mM amino acid mixture and increasing concentrations of glucose (see Table II ).
75-60% in the case of the P--cells, (the remaining 10% is contributed by stroma [31, 32] ). Therefore, the available data have usually been interpreted as being representative for the P-cells. Although this is debatable, we will follow this approach in the following discussion.
Carrier-mediated transport across the cell membrane, as shown to exist in islets, is probably not the critical glucose-sensitive step of P-cells, because fructose, which is unable to stimulate insulin release in the rat, penetrates as rapidly as glucose, presumably via the same carrier system (11) . Further, mannoheptulose blocks insulin release by glucose without interfering with glucose penetration (25) .
If phosphorylation of glucose were the essential event, one would expect that both fructose and 2-deoxyglucose would function as triggers for insulin release, whereas sorbitol and xylitol, sugar alcohols that are not phosphorylated, should not; however, just the opposite is the case ( 11 ) .
The argument in favor of the third, more popular alternative, that of a mechanism dependent on further glucose metabolism, is also not convincing. The most compelling evidence against the general metabolism hypothesis is the recent demonstration with isolated perifused islets that releasing and fuel function of glucose can be completely dissociated with iodoacetate (26) . It is pertinent in this context that neither 5 mM mannose nor 20 mM fructose, which are suitable fuels for the islets, can substitute for glucose in its capacity to sensitize the P-cells to stimulation by isoleucine (17) . Other evidence that the permissive action of glucose is almost certainly not due to provision of energy is derived from studies with the isolated perfused pancreas, in which it was found that ATP and P-creatine levels of islet tissue were the same in the absence and presence of glucose (11) . The observations that metabolite profiles within the islets change only very sluggishly or not at all with glucose and are not correlated with insulin release give further indirect support for an alternate hypothesis explaining glucose-dependent insulin secretion (11) .
Despite the lack of corresponding knowledge concerning the biochemistry of a-cell metabolism, we feel it is fruitful to outline a general working hypothesis for further studies. This hypothesis invokes glucoreceptors and amino acid receptors common to both the a-and P-cell (Fig. 7) . In the case of the P-cell, occupation of amino acid receptor 
